HQC: Unit, Phacofragmentation
What it covers
A phacofragmentation system is an AC-powered device with a fragmenting needle intended for use in cataract surgery to disrupt a cataract with ultrasound and extract the cataract.
The identification in 21 CFR 886.4670, phacofragmentation system. FDA gives HQC no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262097 | MICOR 700 System (N/A); MICOR 700 Extractor (FG-50621) | Carl Zeiss Meditec Cataract Technologies | Oct 15, 2026 | Special |
| K261264 | Stellaris Elite vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite Pack (SE5423); 23 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5423B); 25 ga. Posterior Elite Pack (SE5425); 25 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5425B); 27 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5427B); 23 ga. Bi-Blade+ Vitreous Cutter Posterior Stellaris Elite Pack (SE5423BB+); 25 ga. Bi-Blade+ | Bausch and Lomb | May 15, 2026 | Special |
| K252052 | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) | Bausch and Lomb, Incorporated | Mar 25, 2026 | Traditional |
| K250501 | System Sophi | This AG | Nov 14, 2025 | Traditional |
| K243395 | MICOR 700 with Auto I/A | Carl Zeiss Meditec Cataract Technology, Inc. | Aug 8, 2025 | Traditional |
| K242801 | MICOR 700 System (N/A); MICOR 700 drive (FG-50631); MICOR 700 extractor (FG-50621); MICOR 700 vitrector (FG-51185) | Carl Zeiss Meditec Cataract Technology, Inc. | Jun 11, 2025 | Traditional |
| K240169 | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455) | Bausch and Lomb, Incorporated | Jul 26, 2024 | Traditional |
| K233398 | Faros Surgical System | Oertli Instrumente AG | Jun 27, 2024 | Traditional |
| K233876 | UNITY VCS (8065000296); UNITY CS (8065000297) | Alcon Laboratories, Inc. | Jun 21, 2024 | Traditional |
| K232084 | Stellaris Elite vision enhancement system | Bausch and Lomb | Feb 26, 2024 | Traditional |
Clearances by year
46 HQC 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 115 |
| 2025 | 3 | 267 |
| 2024 | 5 | 197 |
| 2023 | 1 | 124 |
| 2022 | 4 | 245 |
| 2021 | 1 | 155 |
| 2020 | 4 | 227 |
| 2019 | 4 | 126 |
| 2017 | 3 | 214 |
| 2016 | 1 | 86 |
| 2015 | 3 | 124 |
| 2014 | 4 | 135 |
| 2012 | 5 | 125 |
| 2011 | 5 | 129 |
Who submits
20 applicants cleared a HQC device since 2011. 80% of the clearances went to applicants in United States, then Switzerland (7%), Germany (7%) and Netherlands (7%). By type: Traditional 74%, Abbreviated 13% and Special 13%.
| Applicant | Clearances since 2011 |
|---|---|
| Abbott Medical Optics, Inc. | 9 |
| Carl Zeiss Meditec Cataract Technology, Inc. | 7 |
| Alcon Laboratories, Inc. | 3 |
| Carl Zeiss Meditec, AG | 3 |
| Alcon Manufacturing, Ltd. | 2 |
| Bausch & Lomb | 2 |
| Bausch and Lomb | 2 |
| Bausch and Lomb, Incorporated | 2 |
How FDA classifies it
Class II.
From 21 CFR 886.4670.
Standards
21 CFR 886.4670 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HQC clearances declared.
Ask about HQC
Questions about HQC
What is FDA product code HQC?
Product code HQC, “Unit, Phacofragmentation” in FDA's classification database, is a Class II device type under 21 CFR 886.4670 (phacofragmentation system), reviewed by FDA's Ophthalmic panel. FDA's 510(k) database lists 317 clearances under HQC, 46 of them since 2011.
How many 510(k) clearances are there under HQC?
FDA’s 510(k) database listed 317 clearances under HQC as of Oct 29, 2026, 46 of them decided since 2011; the most recent decision was Oct 15, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a HQC 510(k)?
For the 6 HQC clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 267 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most HQC clearances?
Since 2011: Abbott Medical Optics, Inc. (9), Carl Zeiss Meditec Cataract Technology, Inc. (7), Alcon Laboratories, Inc. (3), Carl Zeiss Meditec, AG (3) and Alcon Manufacturing, Ltd. (2). 20 applicants have cleared a HQC device in that time.